Showing results (681-690 of 780) with videos related to

Sort By:
Pageof 78
Health Services Research|March 26, 2003
Quality improvement implementation in the nursing homeDan R Berlowitz, Gary J Young, Elaine C Hickey, et al.
The Journal of Clinical Investigation|December 24, 2008
Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1Katharina Eikermann-Haerter, Ergin Dileköz, Chiho Kudo, et al.
Nature Reviews. Neurology|July 12, 2023
The 5-HT1F receptor as the target of ditans in migraine - from bench to bedsideDimos D Mitsikostas, Christian Waeber, Margarita Sanchez-Del-Rio, et al.
Nature Communications|December 11, 2021
Breast tissue regeneration is driven by cell-matrix interactions coordinating multi-lineage stem cell differentiation through DDR1Gat Rauner, Dexter X Jin, Daniel H Miller, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 1, 2006
fMRI of delayed albumin treatment during stroke recovery in rats: implication for fast neuronal habituation in recovering brainsYoung R Kim, Maurits P A van Meer, Joseph B Mandeville, et al.
Elife|November 8, 2014
Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell stateYarden Katz, Feifei Li, Nicole J Lambert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2017
SMARCE1 is required for the invasive progression of in situ cancersEthan S Sokol, Yu-Xiong Feng, Dexter X Jin, et al.
Cancer Discovery|April 8, 2014
Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stressYu-Xiong Feng, Ethan S Sokol, Catherine A Del Vecchio, et al.
NPJ Precision Oncology|July 21, 2021
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationC B Westphalen, M G Krebs, C Le Tourneau, et al.
NPJ Precision Oncology|June 17, 2025
Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fractionSaumya D Sisoudiya, Hanna Tukachinsky, Rachel B Keller-Evans, et al.
Pageof 78